Navigation Links
New study shows that a cough medicine ingredient could effectively treat prostate cancer
Date:12/18/2008

Baltimore, MD -- A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Researchers found that noscapine, which has been used in cough medication for nearly 50 years, reduced tumor growth in mice by 60% and limited the spread of tumors by 65% without causing harmful side effects.

Prostate cancer is the most common cancer among men in the United States. The American Cancer Society estimates that 186,320 men will be diagnosed with prostate cancer in 2008 and 28,660 will die from it. One man in 6 will get prostate cancer during his lifetime. Although slow-growing in most men, the cancer is considered advanced when it spreads beyond the prostate. There is no known cure.

The laboratory study was a joint effort by Dr. Israel Barken of the Prostate Cancer Research and Educational Foundation, Moshe Rogosnitzky of MedInsight Research Institute, and Dr. Jack Geller of The University of California San Diego. Noscapine has previously been studied as a treatment for breast, ovarian, colon, lung and brain cancer and for various lymphomas, chronic lymphocytic leukemia and melanoma. This study, however, is the first to demonstrate its effectiveness in treating prostate cancer.

Noscapine is a naturally-occurring substance, a non-addictive derivative of opium. As a natural substance, noscapine cannot be patented, which has limited the potential for clinical trials. Rogosnitzky notes that drug companies are generally unwilling to underwrite expensive clinical trials without being able to recoup their investment. A synthetic derivative of noscapine has been patented but has not yet reached the clinical testing phase.

Since noscapine is approved for use in many countries as a cough suppressant, however, it is available to doctors to prescribe for other uses as well. This c
'/>"/>

Contact: Dr. Israel Barken
drbarken@pcref.org
619-461-8181
MedInsight Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Common treatment for mens pelvic pain proves ineffective, Queens-led study shows
2. Study indicates how we make proper movements
3. Study Finds Molecular Link Between Obesity, Hypertension
4. Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
5. Annals colonoscopy study underscores importance of quality standards
6. Study: Sandwich Generation Struggling With Dual Caregiver Responsibilities
7. Recent UC Davis Study Finds Strawberries May Reduce Risk of Heart Disease
8. UIC receives $16 million to study impact of environment on kids health
9. Study examines how breastfeeding impacts cost of care for very low birth weight infants
10. Abused women seek more infant health care, MU study finds
11. New Easter Seals-MassMutual Study: Autism Strains Family Finances, Threatens Long-Term Care and Security
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... 04, 2015 , ... Half of consumers are considering a ... increasingly influential in their choice of practitioner, according to new survey data from ... Cosmetic Dermatologic Procedures reflects overall consumer views on cosmetic medical treatments and ratings ...
(Date:8/4/2015)... ... ... Health Partners) – a Catholic healthcare ministry serving Ohio and Kentucky – has devoted the ... athletes for fall sports. , In a concise video on Mercy Health’s YouTube channel ... steps to take to help prevent injuries , How to see if a ...
(Date:8/4/2015)... ... 04, 2015 , ... More than 700 years of marital bliss were celebrated ... July 24th. Chaplains Shawn Kafader and Richard Oas lead the non-denominational service for ... was a reception, with music by the Moonlight Serenade Orchestra and a special honeymoon ...
(Date:8/4/2015)... ... August 04, 2015 , ... The goal of looking younger – with ... invasive surgery to achieve this ideal is not. But minimally invasive procedures such as ... high cost or lengthy recovery time, according to Valerie Goldburt, MD, PhD , ...
(Date:8/4/2015)... ... August 04, 2015 , ... In ... filed against Johnson & Johnson report that a new location for pretrial proceedings ... regular news updates and cancer warning information at their website, the Talcum Powder ...
Breaking Medicine News(10 mins):Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4Health News:Mercy Health Video Provides Helpful Information for High School Athletes 2Health News:Couples Renew Vows at Friendship Village of Schaumburg 2Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4
... as to why some of the bacteria that cause ... like stomach cancer than others; it turns out these ... them from the immune system. , Helicobacter pylori is ... and induce inflammation, ulcers, and potentially even stomach cancer. ...
... in Vascular Medicine -, FREMONT, Calif., Aug. ... molecular diagnostics company, announced the publication,of data supporting ... were published in the August, 2008 issue of ... by John Cooke, MD, PhD,Professor of Medicine at ...
... of ... PLANO, Texas, Aug. 22 Edition 21, ... International Healthcare, ... (NYSE: PER ) (http://www.perotsystems.com ) continues its series,of podcasts with a forward-looking ...
... at high risk for developing type 2 diabetes might be ... food supplements and making lifestyle changes, according to a new ... on metabolic diseases and weight loss and professor emeritus of ... College of Medicine., Diabetes is a worldwide epidemic, and it ...
... patients can still take the cholesterol-lowering drug , , ... regulators said Thursday that they were investigating whether ... cancer. , The U.S. Food and Drug Administration ... agency was investigating a report from the so-called ...
... LLC,s,partner, Charlotte Orthotic and Prosthetic Center (COPC), announced ... care team as Staff,Prosthetist and will assume the ... Amy is an ABC certified Prosthetist and Orthotist ... a Staff Prosthetist / Orthotist with OrPro in,Maryland. ...
Cached Medicine News:Health News:Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 2Health News:Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 3Health News:Healthcare Tech and the World: A Discussion About Quality Initiatives Pioneered at Ascension Health 2Health News:Healthcare Tech and the World: A Discussion About Quality Initiatives Pioneered at Ascension Health 3Health News:'Nutraceuticals' could prevent diabetes 2Health News:FDA Investigates Possible Vytorin-Cancer Link 2Health News:FDA Investigates Possible Vytorin-Cancer Link 3Health News:Amy Street, Certified Prosthetist and Orthotist, Joins BridgePoint Medical Partner, Charlotte Orthotic and Prosthetic Center (COPC) 2
(Date:8/4/2015)... August 4, 2015 Transparency Market ... Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... new market report published by Transparency Market Research " ... Volume, Share, Growth, Trends and Forecast 2014 - 2022 ...
(Date:8/4/2015)... , Aug. 04, 2015 ... has announced the addition of Jain PharmaBiotech,s new ... Companies" to their offering. This ... application in veterinary medicine and pharmaceuticals as well ... genetics is important in the application of biotechnology ...
(Date:8/4/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... and six months ended June 30, 2015 and updated ... its earnings conference call this morning, August 4, 2015, ... can join the call by dialing (855) 582-8078. The ... , Year-to-date net revenues of $38.3 million, an increase ...
Breaking Medicine Technology:Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16
... Jan. 19, 2011 RFID Journal features ... Someone can live or die depending on the ... agree leveraging better tracking of a drug,s expiration dates, ... levels, all performed in REAL TIME, would assist in ...
... PRINCETON, N.J., Jan. 18, 2011 Pharmasset, Inc. (Nasdaq: ... commenced an underwritten public offering, subject to market and ... pursuant to an effective shelf registration statement.  Of the ... the selling stockholders are selling 1,000,000 shares.  Pharmasset intends ...
Cached Medicine Technology:MEPS Real Time's New RFID Drug Management System Provides Critical Error Solution for California Hospital 2Pharmasset Announces Proposed Public Offering of Common Stock 2Pharmasset Announces Proposed Public Offering of Common Stock 3
Fine & Medium Tapers....
Contour Design Eyelid Implants....
For Frontalis Suspension in patients with significant ptosis and poor levator function....
Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be easily drill...
Medicine Products: